- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Merge enhances software toolkit
Other headlines:Siemens showcases volumetric echo
Merge enhances software toolkit
The latest updates to the DICOM standard and new interfaces using the HL7 standard are part of Merge Healthcare's newly released version of its MergeCOM-3 toolkit. Designed to help network medical products such as scanners and diverse IT products, Version 4.0 supports DICOM enhancements for high-definition video, mammography, and color MRI.
Siemens showcases volumetric echo
Siemens Healthcare is framing its Acuson SC2000 as a new gold standard in echocardiography this week at the American Society of Echocardiography meeting. The latest release of this system features unique technologies that deliver nonstitched real-time full-volume 3D images of the heart acquired in a single heart cycle, according to the company. Siemens is also showcasing the Acuson AcuNav V ultrasound catheter, which delivers real-time volumetric information from inside the heart to support therapeutic ablation procedures and other electrophysiology applications.
Multicenter Study Shows Merits of AI-Powered Ultrasound Assessment for Detecting Ovarian Cancer
January 3rd 2025Adjunctive AI offered greater than seven percent increases in sensitivity, specificity, and accuracy for ultrasound detection of ovarian cancer in comparison to unassisted clinicians who lacked ultrasound expertise, according to findings from new international multicenter research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
